Intellectual Property India Publishes Patent Application for 'Compositions And Methods For The Treatment Of Disorders Related To Cdkl5 Deficiency' Filed by Voyager Therapeutics, Inc.

MUMBAI, India, Nov. 21 -- Intellectual Property India has published a patent application (202517097090 A) filed by Voyager Therapeutics, Inc., Lexington, U.S.A., on Oct. 8, for 'compositions and methods for the treatment of disorders related to cdkl5 deficiency.'

Inventor(s) include Nonnenmacher, Mathieu Emmanuel; Moyer, Tyler Christopher; Li, Jiangyu; and Laks, Dan Richard.

The application for the patent was published on Nov. 21, under issue no. 47/2025.

According to the abstract released by the Intellectual Property India: "The disclosure relates to compositions and methods for altering, e.g., enhancing, the expression of CDKL5 proteins via delivery using an adeno-associated virus (AAV) capsid variant. The compositions and methods of the present disclosure are useful in the treatment of subjects diagnosed with, or suspected of having CDD, or another CDKL5-related disorder."

The patent application was internationally filed on May 01, 2024, under International application No.PCT/US2024/027313.

Disclaimer: Curated by HT Syndication.